Before I took Ovasitol and Berberine Plus I felt horrible. I am thrilled to have found PCOS Diva and start these supplements – I feel great and that makes all the difference while dealing with the unsavory side effects of PCOS. – Tori
Since using the Essentials Bundle, Ovasitol and the Smoothie Bundle I am able to wake up in the mornings without nausea, headaches, and terrible mood swings. I can go about my day without debilitating anxiety and self-doubt and I can finally enjoy my life. Thank you Amy! – Melissa
The Ovasitol, in combination with NAC, has done miles more than any other vitamin has done in restoring my cycle and insulin sensitivity. – Nancy
I purchased the Vitamin D, NAC N-Acetyl Cysteine, and Ovasitol. I chose these PCOS Diva products because of the quality! I love the fact that they are geared toward a vegan, gluten and soy free life as well. I have been able to get off metformin and prescription drugs and just take more natural supplements. – Kristin
Ovasitol is an inositol supplement specifically formulated to promote menstrual regularity and normal ovarian function.* This combination of myo-inositol and D-chiro inositol in the normal 40:1 balance found in a healthy body is based on cutting edge research. Ovasitol may be the supplement you need to:
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
More about Ovasitol:
Ovasitol (from Theralogix) is the first product available which combines two important types of inositol, myo-inositol (MYO) and D-chiro-inositol (DCI), in one package. Its unique combination of two important inositols in a ratio that matches our body’s natural levels is on the cutting edge of research.
Ovasitol contains a tasteless and odorless powder, packaged in a convenient, single-serving packet. It is designed to be mixed with water or other beverage. Each packet provides 2000 mg of myo-inositol and 50 mg of D-chiro-inositol, in the body’s normal ratio of 40 to 1.
For more about the benefits of Ovasitol and inositols:
Abdel, Hamid, Mohamed S. Amr, Madkour Ismail, A. Wael, and Wael Borg. “Inositol versus Metformin Administration in Polycystic Ovary… : Journal of Evidence-Based Women’s Health Journal Society.” Evidence Based Women’s Health Journal. Lippincott Williams & Wilkins, Aug. 2015. Web.
Baillargeon JP M.D., M.Sc.,corresponding author Maria J. Iuorno, M.D., M.Sc., Teimuraz Apridonidze, M.D., M.Sc., and John E. Nestler, M.D. “Uncoupling Between Insulin and Release of a d-Chiro-Inositol–Containing Inositolphosphoglycan Mediator of Insulin Action in Obese Women With Polycystic Ovary Syndrome.” National Center for Biotechnology Information. April 8, 2010. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140116/.
Brink CB, et al. “Effects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells.” Metabolic Brain Diseases, 2004.
Carlomagno G, et al. “Inositol safety: clinical evidences.” European Review for Medical and Pharmacological Sciences, 2011: 931-6.
Colazingari S, et al. “The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.” Archives of Gynecology and Obstetrics, 2013: 1405-11.
Constantino D, et al. “Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.” European Review for Medical and Pharmacological Sciences, 2009: 105-10.
Dinicola S, et al. “The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.” Journal of Clinical Pharmacology, 2014: 1079-92.
Genazzani AD, et al. “Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.” Gynecological Endocrinology, 2008: 139-44.
Iuorno MJ, et al. “Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.” Endocrine Practice, 2002: 417-23.
Kumar SM, et al. “Molecular level interaction of the human acidic fibroblast growth factor with the antiangiogenic agent, inositol hexaphosphate.” Biochemistry, 2010.
Laganà AS. “Myo-Inositol Vs D-Chiro- Inositol: preliminary data on the comparison between their effects on ovarian function and metabolic factors in women with PCOS.” Proceedings of The World Congress on Building Consensus out of Controversies in Gynecology, Infertility and Perinatology. Istanbul, Turkey, 2013.
Larner J, et al. “D-chiro-inositol glycans in insulin signaling and insulin resistance.” Mol Med. Nov-Dec 2010. http://molmed.org/journal/articles/1/32.
Nestler JE. “Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.” New England Journal of Medecine, 1999: 1314-20.
Nordio M, et al. “The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.” European Review for Medical and Pharmacological Sciences , 2012: 575-81.
Rosalbino I, et al. “Does ovary need D-chiro-inositol?” Journal of Ovarian Research, 2012.
Vireday, Pamela. “PCOS Treatment: The Inositols.” Well Rounded Mama. october 31, 2013. http://wellroundedmama.blogspot.com/p/about-this-blog.html.
Zacchè MM, et al. “Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.” Gynecological Endocrinology, 2009: 508-13.